Androgenetic Alopecia: Therapy Update

    May 2023 in “ Drugs
    Shivali Devjani, Ogechi Ezemma, Kristen J. Kelley, Emma Stratton, Maryanne M. Senna
    Image of study
    TLDR There are many treatments for common hair loss, but more trials are needed to decide which are best.
    Androgenetic Alopecia (AGA), a common form of hair loss, affects 80% of men and 50% of women by age 70. The FDA has approved two drugs for AGA: topical minoxidil and oral finoxidil. Other treatments include topical finasteride, dutasteride, oral minoxidil, spironolactone, flutamide, bicalutamide, clascoterone, pyrilutamide, and injectable treatments like botulinum A toxin and dutasteride mesotherapy. Non-drug treatments include Platelet-Rich Plasma (PRP) treatment, Low-Level Light Therapy (LLLT), mesenchymal stem cells (MSCs), microneedling, and nutritional supplements. The document concludes that more large-scale, double-blinded, placebo-controlled randomized trials are needed to make informed decisions about AGA treatments.
    View this study on link.springer.com →

    Cited in this study

    100 / results

    Related

    10 / results